Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$44.36 USD
-0.18 (-0.40%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $44.38 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Price, Consensus and EPS Surprise
AMPH 44.36 -0.18(-0.40%)
Will AMPH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AMPH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AMPH
Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics
Amphastar Pharmaceuticals (AMPH) Tops Q2 Earnings and Revenue Estimates
AMPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 2024 EPS View
UnitedHealth Group (UNH) Q2 Earnings Beat on Strong Optum Unit
Why Amphastar (AMPH) is Poised to Beat Earnings Estimates Again
Other News for AMPH
Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)
Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
The Broad Market Has Not Participated In This Rally
‘Bottom-fishing’ ideas within Piper Sandler’s universe of stocks